AVN-944, 肌苷-5'-单磷酸脱氢酶(IMPDH)抑制剂

CAS: 297730-17-7 货号: A646297 分子式: C25H27N5O5 分子量: 477.51 PubChem CID: 9918559
有货
级别和纯度: Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。 ≥99%
储存条件
-20°C储存
运输条件
超低温运输
★
规格
库存
价格
数量
1mg
A646297-1mg
期货 Stock Image
¥69.90
5mg
A646297-5mg
期货 Stock Image
¥279.90
10mg
A646297-10mg
期货 Stock Image
¥448.90
25mg
A646297-25mg
期货 Stock Image
¥896.90
50mg
A646297-50mg
期货 Stock Image
¥1,523.90
100mg
A646297-100mg
期货 Stock Image
¥2,499.90
请输入您要添加的产品数量
🧪
为什么选择此级别

Moligand™ 级 提供 ≥99% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。

🌡

储存与运输

-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。

📋

质量文档

SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。

📚

文献证明

在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。

概述


AVN-944 (VX-944) is an orally active, potent, selective, noncompetitive and specific inhibitor of IMPDH (inosine monophosphate dehydrogenase). AVN-944 is an essential rate-limiting enzyme in de novo guanine nucleotide synthesis. AVN-944 is also an inhibitor of arenavirus RNA synthesis , and blocks arenavirus infection. AVN-944 has broad anti-cancer activities, and can be used for multiple myeloma (MM) and acute myeloid leukemia (AML) research .

In Vitro

AVN-944 (0-1 μM, 48 h) inhibits growth of human multiple myeloma (MM) cell lines in a dose-dependent manner. AVN-944 (800 nM, 0-72 h) induces apoptosis in MM cell lines via a caspase-independent, Bax/AIF/Endo G pathway. AVN-944 (0-200 nM) enhances the cytotoxicity of Doxorubicin and Melphalan . AVN-944 inhibits the proliferation of the human MV-4-11 and murine Ba/F3-Flt3-ITD-dependent cell lines with IC 50 values of 26 and 30 nM, respectively. AVN-944 (0-32 μM, 48 h) shows good activity against arenavirus infection at low doses (7.5 μM) with less cytotoxicity. AVN-944 (0-6.4 μM, 48 h) does not reduce the viability of peripheral blood mononuclear cells (PBMNCs). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation AssayCell Line: RPMI8226, MM.1S, and U266 cells Concentration: 0, 100, 200, 300, 400, 600, 1000 nM Incubation Time: 48 h Result: Significantly inhibited the growth of RPMI8226, MM.1S, and U266 cells in a dose-dependent fashion, with 50% inhibition (IC 50 ) values at 48 h of 450, 450, and 600 nM, respectively. Inhibited growth of drug-resistant cell lines, including Doxorubicin (Dox)-resistant RPMI8226-Dox40, Melphalan (Mel) resistant RPMI8226-LR5, and Dex (Dexamethasone) resistant MM.1R cells, with IC 50 values similar to the parental drug-sensitive cell lines. Apoptosis AnalysisCell Line: MM.1S and RPMI8226 cells Concentration: 800 nM Incubation Time: 48 and 72 h Result: Induced apoptosis in MM cell lines. Western Blot AnalysisCell Line: MM.1S and RPMI8226 cells Concentration: 800 nM Incubation Time: 12, 24, 48 h Result: Induced modest cleavage of caspase 3, 8 and 9 in MM.1S cells and RPMI8226 cells. Markedly upregulated Bax and Bak, without significant changes in Bcl-2, Mcl-1, XIAP, and Bad. Observed translocation of mitochondrial proapoptotic proteins, apoptosis-inducing factor (AIF) and endonuclease G (Endo G) to cytosolic fractions. Cell Cytotoxicity AssayCell Line: MM.1S cells, MM.1S cells cultured with BMSCs Concentration: 0, 50, 200 nM Incubation Time: 24 h Result: Enhanced the cytotoxicity of of Doxorubicin and Melphalan in MM.1S cells. Additive effects were also observed in MM.1S cells cultured with BMSCs derived from MM patient.

In Vivo

AVN-944 (0-150 mg/kg, Orally, twice daily) significantly increases the median survival time of leukemia model mice. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Balb/c mice (leukemia model, using Ba/F3 cells transduced with an activating human Flt-3 mutation injected into mice)Dosage: 75 or 150 mg/kg Administration: Orally, twice daily Result: Provided a significant increase in median survival time. Three of the 12 mice treated with 150 mg/kg AVN-944 were still alive on Day 35 when the study was terminated.

Form:Solid

规格

英文别名
AVN-944 | HY-13560 | DTXSID80183921 | 501345-02-4 | CARBAMIC ACID, N-((1S)-1-(3-((((3-METHOXY-4-(5-OXAZOLYL)PHENYL)AMINO)CARBONYL)AMINO)PHENYL)ETHYL)-, (1R)-1-(CYANOMETHYL)PROPYL ESTER | NSC-767601 | (R)-1-cyanobutan-2-yl ((S)-1-(3-(3-(3-methoxy-4-(oxazol
规格或纯度
Moligand™, ≥99%
英文名称
AVN-944
生化机理
AVN-944 (VX-944)是一种活性、强效、选择性、非竞争性和特异性的 IMPDH(单磷酸肌苷脱氢酶)抑制剂。AVN-944 是鸟嘌呤核苷酸从头合成过程中一种重要的限速酶。AVN-944 还是一种抑制 IMPDH(肌苷一磷酸脱氢酶)的特异性抑制剂。
储存条件
-20°C储存
运输条件
超低温运输
作用类型
抑制剂
作用机制
肌苷-5'-单磷酸脱氢酶(IMPDH)抑制剂
纯度
≥99%
名称和识别符
分子类型
小分子
IUPAC Name
[(2R)-1-cyanobutan-2-yl] N-[(1S)-1-[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]ethyl]carbamate
INCHI
1S/C25H27N5O5/c1-4-20(10-11-26)35-25(32)28-16(2)17-6-5-7-18(12-17)29-24(31)30-19-8-9-21(22(13-19)33-3)23-14-27-15-34-23/h5-9,12-16,20H,4,10H2,1-3H3,(H,28,32)(H2,29,30,31)/t16-,20+/m0/s1
InChi Key
GYCPCOJTCINIFZ-OXJNMPFZSA-N
Smiles
CC[C@H](CC#N)OC(=O)N[C@@H](C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C3=CN=CO3)OC
Isomeric SMILES
CC[C@H](CC#N)OC(=O)N[C@@H](C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C3=CN=CO3)OC
PubChem CID
分子量
477.51

技术文档

📋 安全数据表 (SDS)

全面的危险、操作、储存及法规合规文件。

下载 SDS →

✅ 分析证书 (COA)

批次质量数据。输入批号以获取对应 COA。

查询 COA →

📊 产品数据表

产品规格和应用的快速参考摘要。

查看数据表 →

🔬 规格说明书

该级别的完整质量属性和验收标准。

查看规格说明 →

高级数据

系统学分类

分类树(Taxonomy Tree)

界(kingdom) 有机化合物
超类(Superclass) 有机杂环化合物
类(Class) 唑类
亚类(Subclass) 噁唑类
中间层级节点(Intermediate Tree Nodes) 暂无
直接上位类(Direct Parent) 苯基-1,3-恶唑
其他上位类(Alternative Parents) N-苯脲类  甲氧基苯胺  苯氧基化合物  甲氧基苯  茴香醚  烷基芳基醚  杂芳族化合物  氨基甲酸酯  尿素  氧环化合物  腈类  氮杂环化合物  有机氧化物  碳氢化合物衍生物  羰基化合物  
分子骨架(Molecular Framework) 芳香族杂单环化合物
取代基(Substituents) 芳基醚 - 茴香醚 - 芳香族杂单环化合物 - 氮杂环 - 苯基化合物 - 脲酸酯 - 碳腈 - 羰基 - 氰化物 - 乙醚 - 杂芳香族化合物 - 烃衍生物 - 甲氧基苯胺 - 甲氧基苯 - 单环苯基基团 - N-吡咯烷酮 - 氰基化合物 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机氮化合物 - 有机氧化合物 - 氧杂环 - 苯酚醚 - 苯氧基化合物 - 苯基-1,3-噁唑 - 脲
描述(Description) 该化合物属于苯基-1,3-恶唑类有机化合物。这类芳香杂环化合物含有1,3-恶唑结构,其一个或多个位置被苯基取代。
外部描述符(External Descriptors) 暂无
三维结构
交互式化学结构模型





产品属性
ALogP 3.1
关联靶点(其它种属)
Hdac6 Histone deacetylase 6 (222 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
rep Replicase polyprotein 1ab (378 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
SARS-CoV-2 (38078 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Vero C1008 (1716 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
作用机制
作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献
化学和物理性质
溶解性
solubility DMSO: 2 mg/mL, clear
分子量
477.500 g/mol
XLogP3
3.100
氢键供体数Hydrogen Bond Donor Count
3
氢键受体数Hydrogen Bond Acceptor Count
7
可旋转键计数Rotatable Bond Count
10
精确质量Exact Mass
477.201 Da
单同位素质量Monoisotopic Mass
477.201 Da
拓扑极表面积Topological Polar Surface Area
139.000 Ų
重原子数Heavy Atom Count
35
形式电荷Formal Charge
0
复杂度Complexity
743.000
同位素原子数Isotope Atom Count
0
定义的原子立体中心计数Defined Atom Stereocenter Count
2
未定义的原子立体中心计数Undefined Atom Stereocenter Count
0
定义的键立体中心计数Defined Bond Stereocenter Count
0
未定义的键立体中心计数Undefined Bond Stereocenter Count
0
所有立体化学键的总数The total count of all stereochemical bonds
0
共价键合单元计数Covalently-Bonded Unit Count
1
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器

常见问题

本产品的 CAS 号、分子式和分子量是多少?
本产品的 CAS 号为 297730-17-7,分子式为 C25H27N5O5,分子量为 477.51 g/mol。InChIKey GYCPCOJTCINIFZ-OXJNMPFZSA-N。